Summary
This study uses massively parallel reporting assays and CRISPR assays to interrogate chromatin accessibility for genetic variants associated with metabolic liver disease, implicating likely causal variants and genes.
Source: Nature.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
